公众号 / 文章重症综合管理与镇静镇痛复苏、休克与脓毒症

优化外周静脉-动脉ECMO期间的氧分压:一项叙述性综述

Optimizing PO2 during peripheral veno-arterial ECMO: a narrative review.
PubMed 文献 · Crit Care · 2022-07-26
一句话结论ELSO指南推荐外周VA-ECMO期间目标氧合器后氧分压约150 mmHg,该阈值证据有限但旨在保留安全边际,避免低氧和严重高氧。

该叙述性综述总结了外周VA-ECMO期间氧合器后氧分压(PPOSTO2)目标约150 mmHg这一ELSO指南推荐的依据与证据。由于氧合器性能,VA-ECMO支持期间动脉高氧常见;双循环现象导致主动脉内氧分压不均一及器官间氧合异质,取决于混合区位置。观察性研究报告高氧与死亡率相关,尤其是难治性心脏骤停后;非ECMO患者中越来越多研究提示过于限制性氧合策略可能有害。将吹扫气氧浓度(FSO2)设定为严格正常氧合具有挑战性,因氧合器后氧饱和度连续监测不广泛可用。

要点

  • ELSO指南推荐外周VA-ECMO期间目标氧合器后氧分压(PPOSTO2)约150 mmHg,证据有限但旨在保留安全边际,避免低氧和严重高氧。
  • VA-ECMO支持期间动脉高氧常见,与氧合器性能有关;观察性研究报告高氧与死亡率相关,尤其难治性心脏骤停后。
  • 双循环现象导致主动脉内氧分压不均一及器官间氧合异质,取决于混合区位置,使氧合解读复杂。
  • 非ECMO患者中越来越多研究提示过于限制性氧合策略可能有害。
  • 设定FSO2以目标严格正常氧合具有挑战性,因氧合器后氧饱和度连续监测不广泛可用。

适用人群与场景

  • 难治性心源性休克和心脏骤停接受外周静脉-动脉体外膜氧合(VA-ECMO)支持的患者。

诊断标准与关键阈值

  • 目标氧合器后氧分压(PPOSTO2)约150 mmHg(ELSO指南推荐)。

处置流程与药物剂量

  • 设定吹扫气氧浓度(FSO2)以目标PPOSTO2约150 mmHg,旨在避免低氧和严重高氧。

研究设计与关键结果

  • 叙述性综述总结ELSO指南推荐PPOSTO2约150 mmHg的依据与证据。
  • 观察性研究报告高氧与死亡率相关,尤其难治性心脏骤停后。
  • 非ECMO患者研究提示过于限制性氧合策略可能有害。
  • 双循环现象导致主动脉内氧分压不均一及器官间氧合异质,取决于混合区位置。
  • 氧合器后氧饱和度连续监测不广泛可用,设定FSO2目标严格正常氧合具有挑战性。

证据类型、等级与局限

  • 证据类型:叙述性综述。
  • PPOSTO2约150 mmHg阈值证据有限。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 接受外周VA-ECMO的难治性心源性休克或心脏骤停患者,按ELSO指南推荐目标PPOSTO2约150 mmHg,避免低氧和严重高氧。
  • 解读氧合时需考虑双循环现象所致主动脉内氧分压不均一及器官间氧合异质。
  • 设定FSO2目标严格正常氧合具有挑战性,因氧合器后氧饱和度连续监测不广泛可用。

指南或共识出处

  • 体外生命支持组织(ELSO)指南。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

During refractory cardiogenic shock and cardiac arrest, veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is used to restore a circulatory output. However, it also impacts significantly arterial oxygenation. Recent guidelines of the Extracorporeal Life Support Organization (ELSO) recommend targeting postoxygenator partial pressure of oxygen (PPOSTO2) around 150 mmHg. In this narrative review, we intend to summarize the rationale and evidence for this PPOSTO2 target recommendation. Because this is the most used configuration, we focus on peripheral VA-ECMO. To date, clinicians do not know how to set the sweep gas oxygen fraction (FSO2). Because of the oxygenator's performance, arterial hyperoxemia is common during VA-ECMO support. Interpretation of oxygenation is complex in this setting because of the dual circulation phenomenon, depending on both the native cardiac output and the VA-ECMO blood flow. Such dual circulation results in dual oxygenation, with heterogeneous oxygen partial pressure (PO2) along the aorta, and heterogeneous oxygenation between organs, depending on the mixing zone location. Data regarding oxygenation during VA-ECMO are scarce, but several observational studies have reported an association between hyperoxemia and mortality, especially after refractory cardiac arrest. While hyperoxemia should be avoided, there are also more and more studies in non-ECMO patients suggesting the harm of a too restrictive oxygenation strategy. Finally, setting FSO2 to target strict normoxemia is challenging because continuous monitoring of postoxygenator oxygen saturation is not widely available. The threshold of PPOSTO2 around 150 mmHg is supported by limited evidence but aims at respecting a safe margin, avoiding both hypoxemia and severe hyperoxemia.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Winiszewski H, Guinot PG, Schmidt M, et al. Optimizing PO2 during peripheral veno-arterial ECMO: a narrative review. Crit Care. 2022. PMID: 35883117. doi:10.1186/s13054-022-04102-0

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。